NOVN.SW
NOVN.SW
CH0012005267
NOVARTIS N
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 56.674.000.000 51.722.000.000
9.6%
Cost of Revenue 13.699.000.000 12.827.000.000
6.8%
Gross Profit 42.975.000.000 38.895.000.000
10.5%
25.331.000.000 24.351.000.000
4.0%
Operating Income 17.644.000.000 14.544.000.000
21.3%
Pretax Income 16.352.000.000 13.640.000.000
19.9%
Net Income Common Stockholders 13.984.000.000 11.941.000.000
17.1%
-- --
--
-- --
--
ende